A Study to Collect Tissue, Fluids, Blood and/or Fungal Samples in Patients with Pulmonary and Extrapulmonary Coccidioidomycosis


About this study

The purpose of this study is to create a biorepository of tissue, fluid and fungal specimens for future studies.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • All patients with confirmed, probable coccidioidomycosis will be eligible.
  • Confirmed infection is identified by positive culture or histopathology/cytology, whereas probable coccidioidal infection is characterized by a combination of positive serology or PCR.
  • Patients may have pulmonary or extrapulmonary coccidioidomycosis, and symptomatic or asymptomatic infection. Patients may have acute, subacute, chronic or resolved infection.


Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Janis Blair, M.D.

Open for enrollment

Contact information:

Lysette Elsner B.S.

(480) 342-6216


More information


Publications are currently not available